KUALA LUMPUR: Bintai Kinden Corp
bhd's partner Generex Biotechnology Corporation has entered a framework agreement with Chinese agencies to develop and commercialise a coronavirus vaccine in China.
It said in a statement issued today that Generex had entered the agreement with China Center for Disease Control and Prevention, Beijing Guoxin Haixiang Equity Investment Partnership and Beijing Youfeng International Consulting Co Ltd.
Already a subscriber? Log in.
Subscribe or renew your subscriptions to win prizes worth up to RM68,000!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
